<DOC>
	<DOCNO>NCT00215592</DOCNO>
	<brief_summary>To determine efficacy safety adjunctive open label Zonegran treatment patient refractory partial seizure .</brief_summary>
	<brief_title>Open Label , Zonegran ( Zonisamide ) In Partial Onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Zonisamide</mesh_term>
	<criteria>1 . Male female patient age 1875 . 2 . Able willing give write informed consent accordance ICH GCP Guidelines . 3 . Female subject childbearing potential must pregnant ( confirm negative serum Î²HCG screen negative urine pregnancy test baseline/during study ) , must lactate must use medically acceptable form contraception study least 1 month discontinuation study drug . Medically acceptable contraception define oral contraceptive pill , surgical sterilization hormonal intrauterine device place least 3 month . Women le 2 year postmenopausal consider childbearing potential . 4 . Focal epilepsy , simple and/or complex partial seizure without secondary generalized seizure define ILAE criterion . 5 . Patients minimum 4 partial seizure 8 week precede baseline visit adequately record use seizure diary card . 6 . Patients receive least 1 2 AEDs concomitant medication , dosage stable least 8 week baseline visit . 1 . History status epilepticus within last 5 year . 2 . Patients know significantly impaired renal function and/or severe hepatic impairment extent protocol dose titration schedule follow . Note Investigators consult include SmPC guide . 3 . Patients suffer clinically significant psychiatric illness , psychological behavioral problem could interfere study participation . 4 . Patients history ( within last 12 month ) alcohol drug abuse dependency . 5 . Patient suffer CNS progressive disease may confound study interpretation , active CNS infection , demyelinate disease degenerative neurological disease . 6 . Patients significant drug sensitivity significant allergic reaction drug include sulfonamide . 7 . Subjects consider Investigator unsuitable candidate receiving Zonegran consider unlikely comply protocol . 8 . Any patient contraindicate Zonegran treatment per attach SmPC . 9 . Any patient pregnant and/or lactating .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>